S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Avoro Capital Advisors/Q3 2023

Avoro Capital Advisors

Periodo: Q3 2023 · Depositato: 2023-11-14
Vedi su SEC EDGAR
AUM
$6.41B
Valore totale del portafoglio
Posizioni
46
Titoli dichiarati
Prima Posizione
HZNP
12.6% $809.8M
Var. Trimestrali
+8 / -5
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2023-11-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
HZNPHORIZON THERAPEUTICS PLC$809.8M12.63%
12.6%
UTHRUNITED THERAPEUTICS CORP$644.3M10.05%$222.14$555.91+150.3%
10.1%
ARGXARGENX SE$491.6M7.67%$487.32$939.68+92.8%
7.7%
SRPTSAREPTA THERAPEUTICS INC$487.9M7.61%$118.59$19.28-83.7%
7.6%
APLSAPELLIS PHARMACEUTICALS INC$422.7M6.59%$37.14
6.6%
SGENSEAGEN INC$373.3M5.82%
5.8%
ASNDASCENDIS PHARMA$343.7M5.36%$91.13$274.50+201.2%
5.4%
BMRNBIOMARIN PHARMACEUTICAL INC$340.6M5.31%$87.08$58.99-32.3%
5.3%
FOLDAMICUS THERAPEUTICS INC$333.2M5.20%
5.2%
KRYSKRYSTAL BIOTECH INC$297.6M4.64%$111.57$375.07+236.2%
4.6%
MRTXMIRATI THERAPEUTICS INC$290.4M4.53%
4.5%
MDGLMADRIGAL PHARMACEUTICALS INC$227.1M3.54%$143.36$528.10+268.4%
3.5%
ALNYALNYLAM PHARMACEUTICALS INC$179.1M2.79%$178.96$312.78+74.8%
2.8%
XENEXENON PHARMACEUTICALS INC$167.4M2.61%$33.06$60.96+84.4%
2.6%
CBAYCYMABAY THERAPEUTICS INC$153.6M2.40%
2.4%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$114.0M1.78%$57.58$18.95-67.1%
1.8%
BCRXBIOCRYST PHARMACEUTICALS INC$81.8M1.28%$6.77$9.84+45.4%
1.3%
ROIVROIVANT SCIENCES LTD$54.3M0.85%$10.52$35.13+233.9%
0.8%
KYMRKYMERA THERAPEUTICS INC$53.6M0.84%$13.57$113.51+736.5%
0.8%
RAREULTRAGENYX PHARMACEUTICAL INC$53.5M0.83%$34.80$33.47-3.8%
0.8%
GPCRSTRUCTURE THERAPEUTICS INC$50.4M0.79%$56.60$53.45-5.6%
0.8%
NUVLNUVALENT INC$37.4M0.58%$45.81$123.73+170.1%
0.6%
MNKDMANNKIND CORP$37.2M0.58%$4.03$4.52+12.2%
0.6%
SNDXSYNDAX PHARMACEUTICALS INC$37.1M0.58%$13.50$21.82+61.6%
0.6%
IOVAIOVANCE BIOTHERAPEUTICS INC$30.5M0.48%$4.43$4.31-2.7%
0.5%
AKROAKERO THERAPEUTICS ORD$28.1M0.44%
0.4%
KURAKURA ONCOLOGY INC$27.2M0.42%$8.60$11.10+29.1%
0.4%
RCKTROCKET PHARMACEUTICALS INC$25.6M0.40%$19.45$3.84-80.3%
0.4%
MRNSMARINUS PHARMACEUTICALS INC$25.4M0.40%
0.4%
TNGXTANGO THERAPEUTICS INC$25.0M0.39%$11.25$29.46+161.9%
0.4%

Attività Trimestre su Trimestre

Q3 2023 vs. Q2 2023

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
GPCRSTRUCTURE THERAPEUTICS INC$50.4M-5.6%
AKROAKERO THERAPEUTICS ORD$28.1M
RCKTROCKET PHARMACEUTICALS INC$25.6M-80.3%
CERECEREVEL THERAPEUTICS HLDNG$20.9M
TSHATAYSHA GENE THERAPIES INC$12.4M
MRUSMERUS N V$10.5M
QQQPUTInvesco QQQ Trust$1.2M
SYREAEGLEA BIOTHERAPEUTICS INC$0.1M

Posizioni Chiuse (5)

TickerEmittenteNozionale
ISEEIVERIC BIO INC$316.7M
DICEDICE THERAPEUTICS INC$102.2M
DSGNDESIGN THERAPEUTICS INC$22.1M
MRSNMERSANA THERAPEUTICS INC$21.0M
AGLEAEGLEA BIOTHERAPEUTICS INC$0.1M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
RAREULTRAGENYX PHARMACEUTICAL INC$18.9M+100.0%-3.8%
ARWRARROWHEAD PHARMACEUTICALS INC$2.4M+58.1%
TNGXTANGO THERAPEUTICS INC$19.6M+35.5%+161.9%
MRTXMIRATI THERAPEUTICS INC$89.7M+20.0%
MLTXMOONLAKE IMMUNOTHERAPEUTICS$26.0M+15.9%-67.1%
MDGLMADRIGAL PHARMACEUTICALS INC$-122.9M+2.6%+268.4%
ASNDASCENDIS PHARMA$24.1M+2.5%+201.2%
KRYSKRYSTAL BIOTECH INC$-3.0M+0.2%+236.2%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
NUVLNUVALENT INC$-30.1M-49.2%+170.1%
ARGXARGENX SE$-0.8M-20.9%+92.8%
ROIVROIVANT SCIENCES LTD$-4.2M-19.9%+233.9%
SRPTSAREPTA THERAPEUTICS INC$-42.1M-13.0%-83.7%
ALNYALNYLAM PHARMACEUTICALS INC$-30.8M-8.5%+74.8%
BCRXBIOCRYST PHARMACEUTICALS INC$-3.1M-4.2%+45.4%
KURAKURA ONCOLOGY INC$-5.7M-4.0%+29.1%
BMRNBIOMARIN PHARMACEUTICAL INC$-6.1M-3.8%-32.3%
Torna agli Hedge Fund